Table 3.
Characteristics of dementia patients according to year of diagnosis (2011~2018).
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Total number | 9248 (100) | 8935 (100) | 9271 (100) | 9625 (100) | 9553 (100) | 9403 (100) | 9206 (100) | 8817 (100) |
| Age | ||||||||
| 60~64 | 520 (5.6) | 531 (5.9) | 523 (5.6) | 550 (5.7) | 602 (6.3) | 574 (6.1) | 577 (6.3) | 510 (5.8) |
| 65~69 | 742 (8.0) | 754 (8.4) | 717 (7.7) | 702 (7.3) | 659 (6.9) | 621 (6.6) | 601 (6.5) | 549 (6.2) |
| 70~74 | 1637 (17.7) | 1477 (16.5) | 1465 (15.8) | 1471 (15.3) | 1330 (13.9) | 1107 (11.8) | 1054 (11.5) | 983 (11.2) |
| 75~79 | 2112 (22.8) | 2118 (23.7) | 2300 (24.8) | 2251 (23.4) | 2216 (23.2) | 2235 (23.8) | 2031 (22.1) | 1975 (22.4) |
| 80~84 | 2107 (22.7) | 2069 (23.2) | 2056 (22.2) | 2250 (23.4) | 2374 (24.9) | 2421 (25.8) | 2422 (26.3) | 2266 (25.7) |
| ≥85 | 2130 (23.0) | 1986 (22.2) | 2210 (23.8) | 2401 (25.0) | 2372 (24.8) | 2445 (26.0) | 2521 (27.4) | 2534 (28.7) |
| Sex, female | 6219 (67.3) | 5961 (66.7) | 6047 (65.2) | 6326 (65.7) | 6129 (64.2) | 6017 (64.0) | 5807 (63.1) | 5529 (62.7) |
| Income, quintile | ||||||||
| <20% | 2387 (25.8) | 2122 (23.8) | 2264 (24.4) | 2387 (24.8) | 2309 (24.2) | 2274 (24.2) | 2285 (27.8) | 2160 (24.5) |
| 20~40% | 841 (9.1) | 875 (9.8) | 819 (8.8) | 975 (10.1) | 929 (9.7) | 911 (9.7) | 952 (10.3) | 894 (10.1) |
| 40~60% | 946 (10.2) | 898 (10.1) | 994 (10.7) | 1018 (10.6) | 997 (10.4) | 1028 (10.9) | 1071 (11.6) | 975 (11.1) |
| 60~80% | 1547 (16.7) | 1515 (17.0) | 1552 (16.7) | 1641 (17.1) | 1593 (16.7) | 1606 (17.08) | 1528 (16.6) | 1486 (16.9) |
| ≥80% | 3527 (38.1) | 3525 (39.5) | 3642 (39.3) | 3604 (37.4) | 3725 (39.0) | 3584 (38.1) | 3370 (36.6) | 3302 (37.5) |
| Comorbidities | ||||||||
| Diabetes | 784 (8.5) | 700 (7.8) | 717 (7.7) | 767 (8.0) | 764 (8.0) | 706 (7.5) | 633 (6.9) | 639 (7.3) |
| COPD | 38 (0.4) | 43 (0.5) | 42 (0.5) | 24 (0.25) | 25 (0.3) | 15 (0.2) | 21 (0.2) | 20 (0.2) |
| CKD | 36 (0.4) | 47 (0.5) | 54 (0.6) | 69 (0.7) | 60 (0.6) | 50 (0.5) | 55 (0.6) | 52 (0.6) |
| Dyslipidemia | 826 (8.9) | 756 (8.5) | 872 (9.4) | 903 (9.4) | 927 (9.7) | 982 (10.4) | 1006 (10.9) | 939 (10.7) |
| Stroke | 1716 (18.6) | 1646 (18.4) | 1611 (17.4) | 1648 (17.1) | 7565 (16.4) | 1549 (16.5) | 1398 (15.2) | 1302 (14.8) |
| Hypertension | 1862 (20.1) | 1694 (19.0) | 1690 (18.2) | 1749 (18.2) | 1687 (17.7) | 1585 (16.9) | 1493 (16.2) | 1328 (15.1) |
| Depression | 1271 (13.7) | 1214 (13.6) | 1303 (14.1) | 1344 (14.0) | 1353 (14.2) | 1345 (14.3) | 1461 (15.9) | 1526 (17.3) |
| Antidementia medication | ||||||||
| Donepezil | 6554 (70.9) | 6717 (75.2) | 7188 (77.5) | 7437 (77.3) | 7636 (79.9) | 7751 (82.4) | 7643 (83.0) | 7321 (83.0) |
| Galantamine | 644 (7.0) | 415 (4.6) | 300 (3.2) | 305 (3.2) | 257 (2.7) | 276 (2.9) | 192 (2.1) | 151 (1.7) |
| Rivastigmine | 1090 (11.8) | 1151 (12.9) | 1167 (12.6) | 1208 (12.6) | 922 (9.7) | 700 (7.4) | 639 (6.9) | 663 (7.5) |
| Memantine | 960 (10.4) | 652 (7.3) | 616 (6.6) | 675 (7.0) | 738 (7.7) | 675 (7.2) | 732 (8.0) | 682 (7.7) |
Data are presented as number (%), unless otherwise indicated.